Announcing Winners of 2016 CompetitionApril 13th, 2017
The Living with Alzheimer’s Film Project today announced the winners of its 2016 Short Film Competition:
GRAND PRIZE ($5,000): “Forgetful, Not Forgotten,” directed by Christopher Wynn
RUNNER UP ($1,000): “Undone,” directed by Hayley Morris
RUNNER UP ($1,000): “Love, Zoë,” directed by Zoë Smurr
YOUNG FILMMAKER PRIZE ($1,000): “Love, Zoë,” directed by Zoë Smurr
“I am humbled by this amazing honor, ” said Grand Prize winner Christopher Wynn, who lives and works in Montreal, Canada. “To truly know what this disease is like and what families go through, you must see, listen to, and share as many stories as possible. We all need to develop more creative projects to help educate the general public and create more awareness around a disease that does not get enough attention. ”
The all-star 2016 Jury consisted of:
- Kim Campbell, Caregiver of husband Glen Campbell and host of CareLiving.org
- Lisa Genova, Author of “Still Alice” and “Inside the O’Briens”
- Anne Basting, Gerontologist and Creator of TimeSlips
- Meryl Comer, President & CEO, Geoffrey Beene Foundation Alzheimer’s Initiative; Author, “Slow Dancing with a Stranger”
- Naomi Boak, Emmy-winning Producer, The Forgetting and Director, Let the Band Play On
- Michael Splaine, Founder of Cognitive Solutions
The project was created by David Shenk, award-winning author of the best-selling book The Forgetting, in conjunction with Cure Alzheimer’s Fund. It was generously funded by MetLife Foundation. Filmmakers of all ages and from across the globe were invited to help others better understand the heartache, exhaustion, unexpected joys, and surreal loss of families dealing with dementia.
“Families toil for years with this disease behind closed doors,” said Shenk. “We wanted to open up their experience to the world.” Through the power of cinema, storytelling and community, Living with Alzheimer’s aims to re-ignite a national dialogue about this ongoing humanitarian crisis.
“It’s so important that we find new ways to convey the urgency of this terrible disease,” said Rudy Tanzi, Ph.D, the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University, Director of the Genetics and Aging Research Unit at Massachusetts General Hospital, and Chair of the Research Consortium at Cure Alzheimer’s Fund. “I’m honored to be a part of a project that will help the public understand what we’re dealing with.”
This was the second year of the short film competition. Each film is judged on story merit, technical achievement, and the extent to which it reveals the challenges of dementia. Eligible films must be under 30 minutes in length to qualify. Visit our About page for more information on eligibility and submissions.
“We’re delighted to work with David Shenk on this important project,” said Tim Armour, President and CEO of Cure Alzheimer’s Fund. “The research community cannot function properly without adequate public support. Compelling films that focus on Alzheimer’s will help engender much-needed support for stopping the disease as soon as possible.”
Submissions for the competition’s third year will be accepted up to January 1, 2018, and winners will be announced in early 2018. All winning films, along with all other qualifying entries, will be included perpetually on the project’s website, livingwithalz.org. “We’re so proud of the invaluable content, and are hopeful that, year after year, this will become a more robust resource for caregivers, ,” says Shenk. We’re essentially building a new online film channel for dementia-specific content. The world needs this.”
About Cure Alzheimer’s Fund
Cure Alzheimer’s Fund is a non-profit dedicated to funding the most promising research to prevent, slow or reverse Alzheimer’s disease. Since its founding in 2004, Cure Alzheimer’s Fund has contributed over $50 million to research, and its funded initiatives have been responsible for several key breakthroughs – including the groundbreaking “Alzheimer’s in a Dish” study. Cure Alzheimer’s Fund has received a score of 100 percent regarding its overall financial health from Charity Navigator and a four star rating from the organization five consecutive times. With 100 percent of funds raised going directly to research, Cure Alzheimer’s has been able to support some of the best scientific minds in the field of Alzheimer’s research. For more information, please visit http://www.curealz.org/
About creator David Shenk
David Shenk is the national-bestselling author of six books, including The Genius in All of Us (“deeply interesting and important” – New York Times). His landmark book about Alzheimer’s disease, The Forgetting (2001), won First Prize in the British Medical Association’s Popular Medical Book Awards, and was welcomed by John Bayley as “the definitive work on Alzheimer’s.” The Los Angeles Times Book Review called it, “a remarkable addition to the literature of the science of the mind.” In January, 2004, PBS broadcast The Forgetting, a prime-time Emmy-winning documentary inspired by the book. In 2006, the book was featured in Sarah Polley’s Oscar-nominated film Away From Her. In 2010, Shenk directed five short animated “pocket films” about Alzheimer’s, narrated by David Hyde Pierce. Shenk has advised the President’s Council on Bioethics on dementia-related issues and is a Senior Advisor to Cure Alzheimer’s Fund. He has also contributed to National Geographic, Slate, The New York Times, The Wall Street Journal, Gourmet, Harper’s, Spy, The New Yorker and NPR. More at davidshenk.com.
About Alzheimer’s Disease
Alzheimer’s is a progressive brain disease that develops at least one decade before symptoms first appear, and eventually leads to problems with memory, reasoning, behavior, and motor skills. Symptoms of Alzheimer’s slowly worsen over time, and the disease is ultimately fatal. Alzheimer’s is the sixth leading cause of death in the U.S., currently afflicting more than five million Americans and costing more than $200 billion annually. Unless there is a cure, those numbers are guaranteed to skyrocket as the population ages. There is currently no available treatment to stop or even slow down the disease.